TY - JOUR
T1 - Differential effects of interleukin-6 receptor activation on intracellular signaling and bone resorption by isolated rat osteoclasts
AU - Moonga, B. S.
AU - Adebanjo, O. A.
AU - Wang, H. J.
AU - Li, S.
AU - Wu, X. B.
AU - Troen, B.
AU - Inzerillo, A.
AU - Abe, E.
AU - Minkin, C.
AU - Huang, C. L.H.
AU - Zaidi, M.
PY - 2002
Y1 - 2002
N2 - The effects of the related cytokines interleukin-6 (IL-6), leukemia inhibitory factor (LIF) and oncostatin-M on bone resorption and cytosolic Ca2+ signaling were compared in isolated rat osteoclasts. In the traditional disaggregated osteoclast (pit) assay, IL-6 and LIF, but not oncostatin-M, conserved the bone resorption otherwise inhibited by high extracellular [Ca2+] (15 mM). It produced a paradoxical, concentration-dependent stimulation of resorption by elevated extracellular Ca2+. In the micro-isolated single osteoclast resorption assay, IL-6, high [Ca2+] or IL-6 plus high [Ca2+] all increased pit formation. In contrast, the IL-6 receptor (IL-6R)-specific agonist antibody MT-18 inhibited bone resorption in a concentration-dependent manner (1:500 to 1:500 000). MT-18 triggered cytosolic Ca2+ signals in fura 2-loaded osteoclasts within ∼ 10 min of application. Each cytosolic Ca2+ transient began with a peak deflection that persisted in Ca2+-free, EGTA-containing extracellular medium, consistent with a release of intracellularly stored Ca2+. This was followed by a sustained elevation of cytosolic [Ca2+] that was abolished in Ca2+-free medium, as expected from an entry of extracellular Ca2+, and by the Ca2+ channel antagonist Ni2+. The inclusion of either IL-6 or soluble human (sh) IL-6R specifically reversed both the above effects of MT-18, confirming that both effects were specific for the IL-6R. The findings suggest that IL-6R activation by IL-6 stimulates osteoclastic bone resorption either by reversing the inhibitory effect of high extracellular Ca2+ in stromal-containing systems or itself stimulating bone resorption along with Ca2+ by micro-isolated osteoclasts. In contrast, activation of the IL-6R by an agonist antibody produces an inhibition of bone resorption and an associated triggering of the cytosolic Ca2+ signals previously associated with regulation of bone resorptive function in other situations.
AB - The effects of the related cytokines interleukin-6 (IL-6), leukemia inhibitory factor (LIF) and oncostatin-M on bone resorption and cytosolic Ca2+ signaling were compared in isolated rat osteoclasts. In the traditional disaggregated osteoclast (pit) assay, IL-6 and LIF, but not oncostatin-M, conserved the bone resorption otherwise inhibited by high extracellular [Ca2+] (15 mM). It produced a paradoxical, concentration-dependent stimulation of resorption by elevated extracellular Ca2+. In the micro-isolated single osteoclast resorption assay, IL-6, high [Ca2+] or IL-6 plus high [Ca2+] all increased pit formation. In contrast, the IL-6 receptor (IL-6R)-specific agonist antibody MT-18 inhibited bone resorption in a concentration-dependent manner (1:500 to 1:500 000). MT-18 triggered cytosolic Ca2+ signals in fura 2-loaded osteoclasts within ∼ 10 min of application. Each cytosolic Ca2+ transient began with a peak deflection that persisted in Ca2+-free, EGTA-containing extracellular medium, consistent with a release of intracellularly stored Ca2+. This was followed by a sustained elevation of cytosolic [Ca2+] that was abolished in Ca2+-free medium, as expected from an entry of extracellular Ca2+, and by the Ca2+ channel antagonist Ni2+. The inclusion of either IL-6 or soluble human (sh) IL-6R specifically reversed both the above effects of MT-18, confirming that both effects were specific for the IL-6R. The findings suggest that IL-6R activation by IL-6 stimulates osteoclastic bone resorption either by reversing the inhibitory effect of high extracellular Ca2+ in stromal-containing systems or itself stimulating bone resorption along with Ca2+ by micro-isolated osteoclasts. In contrast, activation of the IL-6R by an agonist antibody produces an inhibition of bone resorption and an associated triggering of the cytosolic Ca2+ signals previously associated with regulation of bone resorptive function in other situations.
UR - http://www.scopus.com/inward/record.url?scp=18444412566&partnerID=8YFLogxK
U2 - 10.1677/joe.0.1730395
DO - 10.1677/joe.0.1730395
M3 - Article
C2 - 12065229
AN - SCOPUS:18444412566
SN - 0022-0795
VL - 173
SP - 395
EP - 405
JO - Journal of Endocrinology
JF - Journal of Endocrinology
IS - 3
ER -